BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 19691645)

  • 21. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors.
    Akiyoshi T; Uchida K; Tateyama S
    Vet Pathol; 2004 Mar; 41(2):154-63. PubMed ID: 15017029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fine-needle aspiration biopsy of canine mammary gland tumours: a comparison between cytology and histopathology.
    Sontas BH; Yüzbaşıoğlu Öztürk G; Toydemir TF; Arun SS; Ekici H
    Reprod Domest Anim; 2012 Feb; 47(1):125-30. PubMed ID: 21615802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
    de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
    Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammary cancer in the dog: a study of 120 cases.
    Mulligan RM
    Am J Vet Res; 1975 Sep; 36(9):1391-6. PubMed ID: 169716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging technique for the examination of canine mammary tumours.
    Garamvölgyi R; Petrási Z; Hevesi A; Jakab C; Vajda Z; Bogner P; Repa I
    Acta Vet Hung; 2006 Jun; 54(2):143-59. PubMed ID: 16841753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on canine mammary tumours. II. Oestradiol and progesterone receptor binding capacity and histological type.
    Boldizsár H; Muray T; Számel I; Szenci O; Csenki J
    Acta Vet Hung; 1992; 40(1-2):89-97. PubMed ID: 1476094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
    Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
    J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours.
    Petterino C; Rossetti E; Bertoncello D; Martini M; Zappulli V; Bargelloni L; Castagnaro M
    J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):174-8. PubMed ID: 16629950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
    Clemente M; Pérez-Alenza MD; Illera JC; Peña L
    Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canine mammary mixed tumours: immunohistochemical expressions of EGFR and HER-2.
    Bertagnolli AC; Ferreira E; Dias EJ; Cassali GD
    Aust Vet J; 2011 Aug; 89(8):312-7. PubMed ID: 24635633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metallothionein expression in benign and malignant canine mammary gland tumours.
    Erginsoy SD; Sozmen M; Caldin M; Furlanello T
    Res Vet Sci; 2006 Aug; 81(1):46-50. PubMed ID: 16289156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological and immunohistochemical characteristics of two canine lipid-rich mammary carcinomas.
    Pérez-Martínez C; García-Iglesias MJ; Durán-Navarrete AJ; Espinosa-Alvarez J; García-Fernández RA; Lorenzana-Robles N; Fernández-Pérez S; García-Marín JF
    J Vet Med A Physiol Pathol Clin Med; 2005 Mar; 52(2):61-6. PubMed ID: 15737173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
    Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
    J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myoepithelial cell layer integrity in canine mammary carcinoma.
    Sánchez-Céspedes R; Millán Y; Guil-Luna S; García-Monterde J; Reymundo C; Espinosa de los Monteros A; Martín de las Mulas J
    J Comp Pathol; 2011 Jul; 145(1):25-30. PubMed ID: 21247585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.